Filing Flows › Utah Medical Products (UTMD) › Q4 2025
Utah Medical Products (UTMD) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 27, 2026
Utah Medical Products (UTMD) reported revenue of $9.0M for the fourth quarter 2025 (Q4 2025), -1% from a year earlier and -8% from the quarter before. Operating margin was 27.0%, net earnings $2.6M (28.4% of revenue).
Utah Medical Products, Q4 2025: revenue $9.0M (-1% year over year), operating margin 27.0%, net earnings $2.6M, operating cash flow $3.5M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.0M | -8% | -1% |
| Gross profit | $5.3M | -6% | -1% |
| Operating profit | $2.4M | -7% | -17% |
| Net earnings | $2.6M | -3% | -12% |
| Operating cash flow | $3.5M | -10% | +18% |
| Free cash flow | $3.4M | -13% | +15% |
What changed
Revenue was $9.0M in Q4 2025, down 1% year over year and down 8% from the previous quarter.
Gross margin was 58.2%, up 0.1 points from Q4 2024. Operating profit was $2.4M, a 27.0% margin (down 5.0 points year over year). Operating expenses grew 18% against a revenue fall of 1%. The fastest-growing cost line was Research & development (+75%). Net earnings were $2.6M, down 12% year over year. The effective tax rate was 17.4%. Non-operating items added $665K, 21% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $3.5M (up 18% year over year), 136% of net earnings. Non-cash charges added back $745K of depreciation and amortization and $111K of share-based compensation. Capital expenditures of $109K left free cash flow of $3.4M.
Questions
What was Utah Medical Products' revenue in the fourth quarter 2025?
Utah Medical Products (UTMD) reported revenue of $9.0M for the fourth quarter 2025 (Q4 2025), -1% from a year earlier and -8% from the quarter before.
Was Utah Medical Products profitable in the fourth quarter 2025?
Operating profit was $2.4M (27.0% of revenue) and net earnings $2.6M.